Voyager Therapeutics, Inc.

BMV:VYGR * Stock Report

Market Cap: Mex$7.4b

Voyager Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BMV:VYGR * Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Dec 24SellMex$741,393Robin SwartzIndividual6,500Mex$114.06
02 Oct 24SellMex$677,454Jacquelyn SandellIndividual5,999Mex$112.93
02 Apr 24SellMex$222,309Robin SwartzIndividual1,357Mex$163.82
02 Apr 24SellMex$1,980,713Alfred SandrockIndividual12,115Mex$163.49
21 Feb 24SellMex$478,971Peter PfreundschuhIndividual3,764Mex$127.25
21 Feb 24SellMex$1,658,455Alfred SandrockIndividual13,033Mex$127.25
21 Feb 24SellMex$507,636Todd CarterIndividual3,967Mex$131.00
21 Feb 24SellMex$503,999Robin SwartzIndividual3,966Mex$127.08
17 Jan 24SellMex$156,954Todd CarterIndividual1,266Mex$123.98
17 Jan 24SellMex$313,955Robin SwartzIndividual2,543Mex$123.46

Insider Trading Volume

Insider Buying: VYGR * insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of VYGR *?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders604,2691.11%
General Public7,695,99714.1%
Public Companies8,575,31615.7%
Hedge Funds9,117,54616.7%
Institutions28,540,12652.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.2%.

Top Shareholders

Top 25 shareholders own 74.91% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.7%
Neurocrine Biosciences, Inc.
8,575,316Mex$1.2b0%no data
10%
BlackRock, Inc.
5,459,941Mex$736.1m2.77%no data
9.54%
Armistice Capital LLC
5,200,000Mex$701.1m11.3%0.81%
7.18%
EcoR1 Capital, LLC
3,917,546Mex$528.2m0%0.78%
5.57%
The Vanguard Group, Inc.
3,038,564Mex$409.7m-5.98%no data
4.2%
Farallon Capital Management, L.L.C.
2,292,000Mex$309.0m0%0.09%
3.28%
State Street Global Advisors, Inc.
1,789,189Mex$241.2m2.29%no data
2.94%
Great Point Partners, LLC
1,601,527Mex$215.9m0%1.85%
1.97%
Geode Capital Management, LLC
1,072,769Mex$144.6m10.3%no data
1.87%
American Century Investment Management Inc
1,019,332Mex$137.4m32.4%no data
1.81%
T. Rowe Price Group, Inc.
989,549Mex$133.4m-5.03%no data
1.49%
Dimensional Fund Advisors LP
813,680Mex$109.7m-26.4%no data
1.19%
Bank of America Corporation, Asset Management Arm
648,535Mex$87.4m83%no data
1.1%
Vestal Point Capital, LP
600,000Mex$80.9m0%0.26%
1.02%
Federated Hermes, Inc.
554,214Mex$74.7m0.48%0.01%
0.92%
AQR Capital Management, LLC
501,911Mex$67.7m-36.7%no data
0.8%
Morgan Stanley, Investment Banking and Brokerage Investments
437,034Mex$58.9m88.5%no data
0.69%
Northern Trust Global Investments
374,161Mex$50.4m-4.02%no data
0.6%
Goldman Sachs Group, Investment Banking and Securities Investments
324,930Mex$43.8m18.4%no data
0.55%
Woodline Partners LP
300,000Mex$40.4m0%0.02%
0.54%
BNY Asset Management
294,420Mex$39.7m17.7%no data
0.53%
GlobeFlex Capital LP
291,293Mex$39.3m-5.89%0.13%
0.48%
Fiduciary Trust Company
259,397Mex$35.0m0%0.02%
0.46%
JP Morgan Asset Management
249,369Mex$33.6m-13.7%no data
0.45%
Wellington Management Group LLP
246,992Mex$33.3m21.1%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/28 00:30
End of Day Share Price 2024/07/31 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Voyager Therapeutics, Inc. is covered by 25 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Jack AllenBaird
Aydin HuseynovBenchmark Company